Cover Image
市場調查報告書

中國的髖關節重組市場未來趨勢

China Hip Reconstruction Market Outlook to 2021

出版商 GlobalData 商品編碼 296035
出版日期 內容資訊 英文 52 Pages
訂單完成後即時交付
價格
Back to Top
中國的髖關節重組市場未來趨勢 China Hip Reconstruction Market Outlook to 2021
出版日期: 2015年09月01日 內容資訊: 英文 52 Pages
簡介

本報告提供中國的髖關節重組相關市場現狀與未來發展預測相關分析、整體市場規模(以金額、數量為準)的實際成果值、預測值,及市場價格趨勢、市場佔有率現況,再加上主要企業的概要與策略、開發中的產品、最新的市場動靜(資本交易等)等調查,並將結果概述為以下內容。

第1章 目錄

第2章 簡介

第3章 中國的髖關節重組市場

  • 市場收益額的實際成果值(過去8年份)
  • 市場收益額的預測值(今後9年份)
    • 各領域的詳細趨勢(實際成果值、預測值)
  • 市場規模的實際成果值(過去8年份)
  • 市場規模的預測值(今後9年份)
    • 各領域的詳細趨勢(實際成果值、預測值)
  • 平均價格趨勢(總計16年份)
  • 各流通型態市場佔有率(以金額為準)
  • 各企業的市場佔有率(以金額為準)

第4章 主要企業概要

  • DePuy Companies
  • Zimmer Holdings, Inc.
  • Stryker Corporation
  • Smith & Nephew Plc
  • Bonovo Orthopedics, Inc.
  • Biomet, Inc.

第5章 開發中產品

第6章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECC1094DB

GlobalData's new report, "China Hip Reconstruction Market Outlook to 2021", provides key market data on the China Hip Reconstruction market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments - Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement and Hip Resurfacing.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Hip Reconstruction market segments - Primary Hip Replacement, Partial Hip Replacement, Revision Hip Replacement and Hip Resurfacing.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Hip Reconstruction market.
  • Global corporate-level profiles of key companies operating within the China Hip Reconstruction market.
  • Key players covered include Zimmer Holdings, Inc., Stryker Corporation, DePuy Companies, Smith & Nephew Plc, Biomet, Inc. and Wright Medical Group, Inc.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. What Is This Report About?
  • 2.2. Hip Reconstruction Market Segmentation
  • 2.3. Definitions of Markets Covered in the Report

3. Hip Reconstruction Market, China

  • 3.1. Hip Reconstruction Market, China, Revenue ($m), 2007-2014
  • 3.2. Hip Reconstruction Market, China, Revenue ($m), 2014-2021
    • 3.2.1. Partial Hip Replacement Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.2. Primary Hip Replacement Market, China, Revenue ($m), by Segment, 2007-2014
    • 3.2.3. Partial Hip Replacement Market, China, Revenue ($m), by Segment, 2014-2021
    • 3.2.4. Primary Hip Replacement Market, China, Revenue ($m), by Segment, 2014-2021
  • 3.3. Hip Reconstruction Market, China, Volume (Units), 2007-2014
  • 3.4. Hip Reconstruction Market, China, Volume (Units), 2014-2021
    • 3.4.1. Partial Hip Replacement Market, China, Volume (Units), by Segment, 2007-2014
    • 3.4.2. Primary Hip Replacement Market, China, Volume (Units), by Segment, 2007-2014
    • 3.4.3. Partial Hip Replacement Market, China, Volume (Units), by Segment, 2014-2021
    • 3.4.4. Primary Hip Replacement Market, China, Volume (Units), by Segment, 2014-2021
  • 3.5. Hip Reconstruction Market, China, Average Price ($), 2007-2021
  • 3.6. Hip Reconstruction Market, China, Distribution Share by Revenue ($m), 2013-2014
  • 3.7. Hip Reconstruction Market, China, Company Share by Revenue ($m), 2014

4. Overview of Key Companies in China, Hip Reconstruction Market

  • 4.1. Zimmer Biomet Holdings, Inc.
    • 4.1.1. Company Overview
  • 4.2. DePuy Companies
    • 4.2.1. Company Overview
  • 4.3. Stryker Corporation
    • 4.3.1. Company Overview
  • 4.4. Smith & Nephew Plc
    • 4.4.1. Company Overview
  • 4.5. Biomet, Inc. (Inactive)
    • 4.5.1. Company Overview
  • 4.6. Shandong Weigao Orthopaedic Device Co., Ltd.
    • 4.6.1. Company Overview
  • 4.7. Beijing AKEC Medical Co., Ltd.
    • 4.7.1. Company Overview
  • 4.8. Medtronic plc
    • 4.8.1. Company Overview
  • 4.9. Beijing Chunlizhengda Medical Instruments Co., Ltd
    • 4.9.1. Company Overview
  • 4.10. United Orthopedic Corporation
    • 4.10.1. Company Overview
  • 4.11. MicroPort Scientific Corporation
    • 4.11.1. Company Overview

5. Hip Reconstruction Market Pipeline Products

6. Financial Deals Landscape

  • 6.1. Partnerships
    • 6.1.1. DePuy Synthes Enters into Agreement with Radlink
  • 6.2. Private Equity
    • 6.2.1. Blackstone Invests in Suzhou Xinrong Best Medical Instrument

7. Recent Developments

  • 7.1. Other Significant Developments
    • 7.1.1. Dec 31, 2014: MicroPort Orthopedics Reaches Fast Recovery Milestone with 1,000 SuperPath Hip Procedures

8. Appendix

  • 8.1. Research Methodology
    • 8.1.1. Coverage
    • 8.1.2. Secondary Research
    • 8.1.3. Primary Research
    • 8.1.4. Market Modeling and Forecasting
    • 8.1.5. Company Share Analysis
    • 8.1.6. Distribution Share Analysis
  • 8.2. Expert Panel
  • 8.3. GlobalData Consulting
  • 8.4. Contact Us
  • 8.5. Disclaimer

List of Tables

  • Table 1: Hip Reconstruction Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 2: Hip Reconstruction Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 3: Partial Hip Replacement Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 4: Primary Hip Replacement Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Table 5: Partial Hip Replacement Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 6: Primary Hip Replacement Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Table 7: Hip Reconstruction Market, China, Volume (Units), Historic, 2007-2014
  • Table 8: Hip Reconstruction Market, China, Volume (Units), Forecast, 2014-2021
  • Table 9: Partial Hip Replacement Market, China, Volume (Units), Historic, 2007-2014
  • Table 10: Primary Hip Replacement Market, China, Volume (Units), Historic, 2007-2014
  • Table 11: Partial Hip Replacement Market, China, Volume (Units), Forecast, 2014-2021
  • Table 12: Primary Hip Replacement Market, China, Volume (Units), Forecast, 2014-2021
  • Table 13: Hip Reconstruction Market, China, Average Price ($) Historic, 2007-2014
  • Table 14: Hip Reconstruction Market, China, Average Price ($), Forecast, 2014-2021
  • Table 15: Hip Reconstruction Market, China, Distribution Share by Revenue ($m), USD Constant, 2013-2014
  • Table 16: Hip Reconstruction Market, China, Company Share by Revenue ($m), USD Constant, 2014
  • Table 17: Hip Reconstruction Market Pipeline Products
  • Table 18: DePuy Synthes Enters into Agreement with Radlink
  • Table 19: Blackstone Invests in Suzhou Xinrong Best Medical Instrument
  • Table 20: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country

List of Figures

  • Figure 1: Hip Reconstruction Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 2: Hip Reconstruction Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 3: Partial Hip Replacement Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 4: Primary Hip Replacement Market, China, Revenue ($m), USD Constant, Historic, 2007-2014
  • Figure 5: Partial Hip Replacement Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 6: Primary Hip Replacement Market, China, Revenue ($m), USD Constant, Forecast, 2014-2021
  • Figure 7: Hip Reconstruction Market, China, Volume (Units), Historic, 2007-2014
  • Figure 8: Hip Reconstruction Market, China, Volume (Units), Forecast, 2014-2021
  • Figure 9: Partial Hip Replacement Market, China, Volume (Units), Historic, 2007-2014
  • Figure 10: Primary Hip Replacement Market, China, Volume (Units), Historic, 2007-2014
  • Figure 11: Partial Hip Replacement Market, China, Volume (Units), Forecast, 2014-2021
  • Figure 12: Primary Hip Replacement Market, China, Volume (Units), Forecast, 2014-2021
  • Figure 13: Hip Reconstruction Market, China, Company Share (%) 2014
  • Figure 14: GlobalData Epidemiology-Based Forecasting Model
  • Figure 15: GlobalData Capital Equipment-Based Forecasting Model
  • Figure 16: Primary Interviews by Participant Type (%)
Back to Top